Navigation mit Access Keys

Main Content

CV of Prof. Dr. Markus A. Ruegg

ORCID 0000-0002-4974-9384
Nationality: Swiss
Since 2021 –  Co-founder and CEO of SEAL Therapeutics Ltd.
Since 2004 –  Full Professor of Neurobiology
1998 – 2004 Associate Professor of Neurobiology
1992 – 1997 Assistant Professor
1989 – 1992 Postdoctoral Fellow, Department of Neurobiology, Stanford University School of Medicine
1985 – 1988 Graduate Studies in Biochemistry and Neurobiology, Institute of Biochemistry University of Zurich
1979 – 1985 Studies of Biochemistry at the University of Zurich
1975 – 1979 Kantonsschule Aarau, Aarau, Switzerland, Matura Typus B
Selected Awards & Honors:
2021 Lelio Orci Award from Life Sciences Switzerland
2000 Robert Bing Prize from the Swiss Academy of Medical Sciences
1989 Faculty of Sciences of the University of Zürich: Distinction for Ph.D. thesis
Selected Memberships:
Since 2021 – Vice-President of the Swiss Foundation for Research and Muscle Diseases (FSRMM)
Since 2021 –  President of the Animal Ethics Commission of the Kantons of Basel-Stadt, Basel-Landschaft and Aargau.
Since 2020 –  Co-Editor in Chief Skeletal Muscle
Since 2020 – 

Editorial Board of “Current Research in Physiology”

Since 2017 –

Section head of Musculoskeletal Pharmacology of “Faculty1000Prime”

Since 2017 –

Editorial Board of “Current Opinion in Physiology”

Since 2014 –

Associate Editor of "Journal of Neuromuscular Diseases"

2014 – 2020 Member of the ENMC research committee
Since 2013 –

Chairman of the Scientific Advisory Committee of the Swiss Foundation for Research and Muscle Diseases (FSRMM)

2012 – 2018 Member of the Medical Research Committee of “Muscular Dystrophy Campaign” UK
Since 2009 –

Scientific and Medical Advisory Board of "Cure CMD"

2000 – 2007 Council member of the Swiss Society for Neuroscience